GET A QUOTE

Role of 2,5-Oligoadenylate Synthetase (2,5-OAS) in Fighting Viral Infections

Introduction

The 2,5-Oligoadenylate synthetase (2,5-OAS) essential, in the body’s defence against infections as part of the immune systems response mechanism triggered by interferon signalling pathways when viruses invade host cells is found in various cell types, like epithelial and immune cells aiding in the overall antiviral protection of the body. The identification and analysis of it have marked advancements in comprehending the relationship, between viruses and the body’s natural defence system.

The arrangement and functioning of 2,5-OAS

2,5-OAS enzyme is responsible for catalysing the synthesis of 2′,5′-linked oligoadenylates (2-5A) from ATP. This process is activated in the presence of stranded RNA (dsRNA) which is a common byproduct formed during viral replication processes. The binding of dsRNA triggers a structural change, in the enzyme allowing it to produce molecules of 2,5-OAS more efficiently. The enzyme has sections that play a role, in both its binding to dsRNA and its catalytic functions; an oligomerisation domain at the N terminal end; a catalytic domain in the middle; and a dsRNA binding domain at the C terminal end. Researchers have extensively studied the ways in which 2′,5′-oligoadenylate synthetase interacts with dsRNA at a level to gain insights, into how the enzyme gets activated.

Exploring the Function in Fighting Viral Infections

The molecules known as 2-5A acts as a secondary messenger, activating RNAase L which then decomposes both cellular RNA effectively stopping viral replication and causing infected cells to undergo apoptosis. This series of actions is a part of the body’s defence, against viruses mediated by interferons. The presence of these molecules causes RNase L to become active by binding to it and causing a change, in its structure leading it to work as an enzyme. The breakdown of RNA that occurs as a result disturbs functions, within cells like making proteins. May cause infected cells to destroy themselves to prevent the virus from spreading further—a crucial antiviral action known for its effectiveness, in the 2,5-OAS/RNase L induced pathway.

Controlling the expression of 2,5-OAS

The 2, 5-OAS genes activity spikes, due to type I interferons released by cells when encountering an attack. This boost enables the cell to swiftly elevate its levels of 2, 5-OAS and launch a defence against viruses. The 2,5-OAS gene is one of genes activated by interferon-stimulated genes (ISGs) that are crucial, in fighting off viruses triggered by interferon reactions. Regulating the expression of 2′ 5′ oligoadenylate synthetase involves a process that includes controlling transcription and post transcriptional mechanisms along, with making changes. Understanding these pathways is vital for uncovering how cells manage their defences against viruses effectively. Mutations or deficiencies in the 2′, 5′-Olgaadenylate synthetase enzyme can make individuals more susceptible to infections because it hampers the interferon mediated antiviral response pathway.

Significance in Clinical Practice and Potential for Treatment

Furthermore¸ scientists are exploring the use of 2¸5-OAS as a biomarker, for infections¸ as its levels of activity could offer important clues into the hosts response to viruses¸ such as how well its antiviral defences are working¸ The understanding of how 2¸5-OAS is controlled and its role is also significant for improving treatments that enhance the immune system and managing conditions like autoimmune disorders¸ where problems, with the 2¸5-OAS/RNase L pathway have been connected.

Suitable ELISA Kits

Online Enquiry Form

"*" indicates required fields

Please check mark information required:

TESTIMONIALS arrow icon

Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford